Selank: adjunctive chronic-dermatosis method — RU2709534C1
Луиза Афгатовна Юсупова, Евгения Владимировна Бильдюк · 2019 · RU2709534C1 · patent family 69006604
Published 2019-12-18.
Reported patent results
Reported findings
The patent reports reductions in skin-severity and psychological scores, alongside standard topical treatment.
Three illustrated dermatosis cases receiving topical hydrocortisone plus adjunctive Selank; no adequately documented randomized comparison.
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Psoriasis case | PASI 13 → 1; Beck depression 12 → 5; Hamilton anxiety 17 → 7 | Single-patient before/after findings · Skin findings described through day 15 |
| Eczema case | EASI 9 → 1; Beck depression 11 → 4 | Single-patient before/after findings · Skin findings described through day 16 |
| Atopic dermatitis case | SCORAD 23 → 9 | Single-patient before/after finding · Skin findings described through day 13 |
| Comparative effectiveness statement | The text claims 87.6% clinical improvement, but does not provide a usable group denominator or a clear comparative effect calculation | This percentage is not entered as a verified treatment effect |
Concurrent steroid treatment, selected cases and incomplete comparator reporting prevent attribution to Selank. The source has a mg/µg dosing inconsistency; no regimen is reproduced.
Source for the extracted data ↗ · Checked 2026-11-06
Patent claims and provenance
Use. The filing proposes Selank alongside care for chronic dermatoses.
Concurrent care prevents simple attribution; the document also contains a dose-unit inconsistency, so no administration regimen is reproduced here.
- Publication
- RU2709534C1 ↗ · 2019-12-18
- Earliest priority / filing
- 2018-07-12 / 2018-07-12
- Original applicant / assignee
- Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России)
- Indexed status
- Not shown; official status unverified · checked 2026-11-06
- Patent family
- 69006604 · family publications are related filings, not independent studies.
Original title, inventors and related publications
Method of treating chronic dermatoses
Inventors: Луиза Афгатовна Юсупова; Евгения Владимировна Бильдюк.
Molekul summary of the linked publication. Educational information, not medical advice. Seek qualified healthcare help for medical conditions.
Methods, limitations & source review
Study limitations
- Concurrent care prevents simple attribution; the document also contains a dose-unit inconsistency, so no administration regimen is reproduced here.
- Concurrent steroid treatment, selected cases and incomplete comparator reporting prevent attribution to Selank. The source has a mg/µg dosing inconsistency; no regimen is reproduced.
- Patents record claimed inventions and supporting disclosures. Publication or grant does not establish clinical efficacy, safety or marketing approval. Members of one patent family and related journal reports can describe the same experiments.
- Status labels are Google Patents index snapshots for the displayed publication or application; the record gives its source-check date. Official registers and every national family member have not been independently checked. These labels do not establish freedom to operate.
Publication counts are not counts of independent trials. Reviews, translations and reports sharing participants may overlap. Findings apply to the studied preparation, population and endpoints.
Document format: Original patent text and indexed metadata
Review depth: Claims, selected reported findings and limitations reviewed; supporting experiments not comprehensively appraised.
Related-report group: patent-family-69006604. Reports in this group are not assumed to be independent trials.
Source access and review scope
Original patent publication accessed through Google Patents. Claims, selected reported findings and source limitations checked. The results section identifies the examples, tables and any numerical extraction gaps. No complete experimental audit, prosecution review or legal claim construction was performed.
Recorded source-check date: 2026-11-06. This date does not imply a completed systematic review.
Source type: Patent publication
Citation and original source
Original source: Луиза Афгатовна Юсупова, Евгения Владимировна Бильдюк. Selank: adjunctive chronic-dermatosis method — RU2709534C1 RU2709534C1 · patent family 69006604 2019.
Molekul research summary: https://molekul.io/research/patent-ru2709534c1. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry